Oncology Institute Inc.

NASDAQ: TOI · Real-Time Price · USD
3.56
-0.11 (-3.00%)
At close: Aug 15, 2025, 12:36 PM

Oncology Institute Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-65.89M -64.36M -64.66M -70.23M -71.54M -72.96M -83.07M -73.82M -59.07M -47.63M 1.66M 1M 696.63K 9.36M -10.93M -9.28M -3.28M -5.47M
Depreciation & Amortization
6.87M 6.58M 6.29M 6.16M 6.28M 6.09M 5.87M 5.49M 4.92M 4.69M 4.41M 4.14M 3.85M 3.55M 3.34M 3.21M 3.15M 3.16M
Stock-Based Compensation
5.89M 8.52M 11.15M 13.94M 16.21M 16.93M 17.81M 19.8M 21.69M 24.09M 27.68M 45.99M 39.51M 33.05M 24.53M 190.33K 167.61K 158.89K
Other Working Capital
12.33M 7.3M 10.97M 8.04M 5.61M 11.52M 11.08M 9.09M 10.37M 11.31M 7.71M -3.96M -4.72M -12.87M -13.37M -5.28M -6.49M 1.09M
Other Non-Cash Items
18.82M 9.69M 2.63M 3.87M 6.15M 8.83M 20.79M 11.76M -9.88M -23.64M -74.75M -96.71M -78.78M -71.91M -33.9M 2.72M -310.26K -4.38M
Deferred Income Tax
-32K n/a n/a -126K -46K -50K -76K -396K -424K -469K -263K 2.48M -1.33M -1.28M -1.24M -3.54M 220.74K 221K
Change in Working Capital
24.16M 23.92M 18.06M 11.77M -803K 4.4M 2.36M -9.26M -15.75M -17.28M -20.5M -28M -17.32M -22.88M -14.49M -809.52K -8.45M -1.1M
Operating Cash Flow
-10.19M -15.64M -26.54M -34.62M -43.75M -36.75M -36.31M -46.42M -58.51M -60.23M -61.76M -71.09M -53.37M -50.13M -32.68M -8.34M -10.16M -9.07M
Capital Expenditures
-2.89M -3.51M -3.79M -2.9M -4.23M -3.34M -4.57M -5.7M -5.96M -6.37M -5.53M -4.41M -4.16M -3.43M -3.05M -2.53M -1.85M -1.48M
Cash Acquisitions
n/a n/a n/a -156K -8.79M -13.1M -33.34M -33.65M -24.2M -28.82M -8.58M -16.39M -17.2M -8.28M -9.11M -827K -827.46K -977K
Purchase of Investments
n/a n/a n/a 88K 152K 164K -9.6M -39.79M -127.25M -127.27M -117.51M -87.4M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
10M 30M 50M 62.56M 61.13M 71.26M 81.26M 99.28M 177.29M 147.16M 117.17M 86.59M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
126K 126K n/a n/a 8.64M 38.78M 59.02M 28.44M -66.78M -96.92M -117.17M -86.59M n/a 300K 300K 221.46M -325.53K -625.53K
Investing Cash Flow
7.24M 26.62M 46.21M 59.59M 56.9M 63.63M 62.64M 18.44M -77.05M -112.21M -131.61M -108.19M -21.36M -11.71M -12.15M 218.15M -2.68M -2.45M
Debt Repayment
-161K -20.04M -39K -39K -38K -92K -101K -110K 109.89M 109.94M 109.94M 104.42M -5.58M -10.07M -7.66M -2.22M -2.31M 7.08M
Common Stock Repurchased
n/a n/a n/a n/a -125K -125K -125K -125K -9M -18M -18M -18M -9M n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-20.51M -2.54M -3.46M -5.26M -5.65M -6.04M -6.73M -5.26M -9.23M -8.7M -8.66M 113.42M 118.02M 120.03M 121.67M 49.5K 219.59M 219.59M
Financial Cash Flow
-3.18M -7.29M -3.49M -5.11M -5.62M -6.08M -6.85M -5.91M 100.24M 92.15M 92.21M 229.18M 123.78M 129.96M 154.01M 17.83M 17.74M 27.13M
Net Cash Flow
-6.13M 3.68M 16.18M 19.87M 7.53M 20.8M 19.48M -33.89M -35.32M -80.28M -101.16M 49.89M 49.04M 68.12M 109.18M 10.53M 4.9M 15.61M
Free Cash Flow
-13.07M -19.15M -30.33M -37.51M -47.97M -40.08M -40.88M -52.12M -64.47M -66.59M -67.28M -75.5M -57.54M -53.55M -35.73M -10.87M -12.01M -10.54M